Tiedemann Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$318K Hold
7,263
0.01% 212
2023
Q2
$359K Hold
7,263
0.02% 189
2023
Q1
$301K Hold
7,263
0.01% 203
2022
Q4
$322K Hold
7,263
0.02% 191
2022
Q3
$284K Hold
7,263
0.02% 190
2022
Q2
$297K Hold
7,263
0.02% 186
2022
Q1
$477K Hold
7,263
0.02% 192
2021
Q4
$505K Hold
7,263
0.02% 187
2021
Q3
$505K Hold
7,263
0.03% 192
2021
Q2
$576K Hold
7,263
0.02% 222
2021
Q1
$476K Hold
7,263
0.02% 217
2020
Q4
$404K Hold
7,263
0.02% 227
2020
Q3
$290K Hold
7,263
0.01% 266
2020
Q2
$326K Hold
7,263
0.02% 243
2020
Q1
$244K Hold
7,263
0.02% 258
2019
Q4
$236K Buy
+7,263
New +$207K 0.01% 272
2019
Q3
Sell
-7,263
Closed -$217K 300
2019
Q2
$217K Buy
+7,263
New +$212K 0.01% 275
2019
Q1
Sell
-7,263
Closed -$222K 445
2018
Q4
$222K Hold
7,263
0.01% 383
2018
Q3
$254K Buy
+7,263
New +$230K 0.02% 275

Other funds holding ATRC

Tiedemann Advisors's ATRC Position: Q3 2023 in Review

Tiedemann Advisors held its AtriCure (ATRC) position steady in Q3 2023 at 7,263 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #212.

Tiedemann Advisors first reported a position in ATRC in Q3 2018 and has held it in 19 quarters since. The position peaked at $576K in Q2 2021. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • Tiedemann Advisors held 7,263 shares of AtriCure worth $318K as of Q3 2023.
  • Tiedemann Advisors left its AtriCure share count unchanged in Q3 2023.
  • AtriCure made up 0.01% of Tiedemann Advisors's portfolio in Q3 2023, its #212 holding.
  • Tiedemann Advisors first reported a position in AtriCure in Q3 2018 and has held it in 19 quarters since.
  • Tiedemann Advisors's AtriCure position peaked at $576K in Q2 2021.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.